Condition: Mechanical Ventilation · Tracheal Intubation · Ventilator-acquired Pneumonia · Sponsor: Assistance Publique - Hôpitaux de Paris
Hypothesis: Nosten® device is able to reduce the time of underinflated balloon and removes excess pressure. This device may thus reduce the risk of ventilator-acquired pneumonia (VAP) and early tracheal lesions resulting from intubation with decreased discomfort, morbidity, and nursing workload. The main objective of the investigators is to show that Nosten® device is more effective than monitoring and manual inflation of the balloon of the tracheal tube to prevent VAP occurrence.
This description comes directly from the study's public registry record.
Bruno MEGARBANE, MD, PhD · (+33)1 49 95 64 91 · bruno.megarbane@aphp.fr
Always discuss trial participation with your own doctor first.
| Service de Réanimation Médical et Toxicologique | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02514655